NCT03287427View on ClinicalTrials.gov

MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 22, 2018

Primary Completion Date

December 14, 2022

Study Completion Date

December 14, 2022

Conditions
Colorectal CancerAdenoid Cystic Carcinoma
Interventions
DRUG

TetMYB Vaccine

Weekly intra-dermal injections of either 0.1mg, 0.5mg or 1.0mg on day 1 for week 1 to week 6.

DRUG

BGB-A317

3 weekly IV injections of 200mg commencing from Week 4.

Trial Locations (1)

3000

Peter MacCallum Cancer Centre, Melbourne

All Listed Sponsors
lead

Peter MacCallum Cancer Centre, Australia

OTHER

NCT03287427 - MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial | Biotech Hunter | Biotech Hunter